NYSE:AVTR - Avantor Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $24.68
  • Forecasted Upside: -6.35 %
  • Number of Analysts: 17
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 15 Buy Ratings
  • 0 Strong Buy Ratings
$26.35
▲ +0.31 (1.19%)
1 month | 3 months | 12 months
Get New Avantor Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AVTR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AVTR

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$24.68
▼ -6.35% Downside Potential
This price target is based on 17 analysts offering 12 month price targets for Avantor in the last 3 months. The average price target is $24.68, with a high forecast of $33.00 and a low forecast of $18.00. The average price target represents a -6.35% upside from the last price of $26.35.
Buy
The current consensus among 17 investment analysts is to buy stock in Avantor.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/6/2019
  • 0 strong buy ratings
  • 20 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/4/2019
  • 0 strong buy ratings
  • 20 buy ratings
  • 2 hold ratings
  • 0 sell ratings
12/3/2019
  • 0 strong buy ratings
  • 21 buy ratings
  • 2 hold ratings
  • 0 sell ratings
3/2/2020
  • 0 strong buy ratings
  • 22 buy ratings
  • 2 hold ratings
  • 0 sell ratings
5/31/2020
  • 0 strong buy ratings
  • 11 buy ratings
  • 3 hold ratings
  • 0 sell ratings
8/29/2020
  • 0 strong buy ratings
  • 13 buy ratings
  • 3 hold ratings
  • 0 sell ratings
10/28/2020
  • 0 strong buy ratings
  • 15 buy ratings
  • 2 hold ratings
  • 0 sell ratings
11/27/2020

Latest Recommendations

  • 0 strong buy ratings
  • 15 buy ratings
  • 2 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/9/2020KeyCorpUpgradeSector Weight ➝ Overweight$33.00High
i
10/30/2020Smith Barney CitigroupBoost Price Target$24.00 ➝ $28.00Medium
i
10/29/2020JPMorgan Chase & Co.Boost Price TargetOverweight$25.00 ➝ $28.00Medium
i
10/29/2020Morgan StanleyBoost Price TargetOverweight$24.00 ➝ $27.00Low
i
10/29/2020Robert W. BairdBoost Price TargetOutperform$23.00 ➝ $27.00Low
i
10/28/2020Wells Fargo & CompanyBoost Price TargetOverweight$23.00 ➝ $28.00High
i
10/12/2020Raymond JamesBoost Price TargetOutperform$23.00 ➝ $27.00Low
i
10/9/2020Jefferies Financial GroupBoost Price TargetBuy$25.00 ➝ $30.00Low
i
9/14/2020Morgan StanleyInitiated CoverageOverweight$24.00Medium
i
8/3/2020Truist FinancialBoost Price TargetBuy$21.00 ➝ $29.00Medium
i
7/30/2020Stifel NicolausBoost Price TargetHold$18.00 ➝ $21.50High
i
7/30/2020Raymond JamesBoost Price TargetOutperform$17.00 ➝ $23.00Low
i
7/30/2020JPMorgan Chase & Co.Boost Price TargetOverweight$18.00 ➝ $25.00High
i
7/30/2020Piper SandlerBoost Price TargetNeutral$16.00 ➝ $21.00High
i
7/28/2020Credit Suisse GroupBoost Price TargetOutperform$18.00 ➝ $21.00Medium
i
7/15/2020Cleveland ResearchUpgradeNeutral ➝ BuyHigh
i
4/30/2020CSFBLower Price TargetOutperform$20.00 ➝ $18.00Low
i
4/30/2020Credit Suisse GroupLower Price TargetOutperform$20.00 ➝ $18.00Medium
i
4/30/2020CitigroupBoost Price TargetBuy$16.00 ➝ $19.00Medium
i
4/30/2020Stifel NicolausBoost Price TargetHold$15.00 ➝ $18.00High
i
4/30/2020Raymond JamesLower Price TargetOutperform$19.00 ➝ $17.00High
i
4/28/2020UBS GroupLower Price TargetBuy$22.00 ➝ $20.00High
i
4/2/2020Stifel NicolausLower Price TargetHold$16.00 ➝ $15.00Medium
i
3/26/2020BarclaysLower Price TargetOverweight$21.00 ➝ $19.00Medium
i
3/20/2020CitigroupLower Price TargetBuy$22.00 ➝ $11.00High
i
2/10/2020Raymond JamesLower Price TargetOutperform$20.00 ➝ $19.00High
i
2/7/2020CowenReiterated RatingBuy$23.00High
i
Rating by Doug Schenkel at Cowen Inc
1/7/2020Wells Fargo & CompanyInitiated CoverageOverweight$22.00Medium
i
1/7/2020CitigroupInitiated CoverageBuy$21.00High
i
11/14/2019Stifel NicolausInitiated CoverageHoldLow
i
11/5/2019Piper Jaffray CompaniesLower Price TargetNeutral$17.00 ➝ $15.00High
i
8/2/2019Cleveland ResearchInitiated CoverageNeutral ➝ NeutralHigh
i
7/18/2019BarclaysReiterated RatingBuy$22.00Medium
i
6/26/2019Janney Montgomery ScottReiterated RatingBuy$27.00 ➝ $18.70Low
i
6/14/2019Janney Montgomery ScottInitiated CoverageBuyLow
i
6/12/2019Raymond JamesInitiated CoverageOutperform$20.00High
i
6/11/2019GuggenheimInitiated CoverageBuy ➝ Buy$21.00Low
i
6/11/2019Bank of AmericaInitiated CoverageBuy ➝ Buy$22.00Low
i
6/11/2019Royal Bank of CanadaInitiated CoverageOutperform ➝ Outperform$22.00Low
i
6/11/2019Evercore ISIInitiated CoverageOutperform ➝ Outperform$23.00Low
i
6/11/2019Jefferies Financial GroupInitiated CoverageBuy ➝ BuyMedium
i
6/11/2019Credit Suisse GroupInitiated CoverageOutperform ➝ Outperform$20.00Medium
i
6/11/2019Robert W. BairdInitiated CoverageOutperform ➝ Outperform$20.00High
i
6/11/2019William BlairInitiated CoverageOutperform ➝ OutperformHigh
i
Rating by B. Weinstein at William Blair
6/11/2019KeyCorpInitiated CoverageSector Weight ➝ Sector WeightMedium
i
6/11/2019SunTrust BanksInitiated CoverageBuy ➝ Buy$22.00Medium
i
6/11/2019CitigroupInitiated CoverageBuy ➝ Buy$21.00Medium
i
6/11/2019BarclaysInitiated CoverageOverweight ➝ Overweight$20.00Medium
i
6/11/2019Deutsche Bank AktiengesellschaftInitiated CoverageBuy ➝ Buy$21.00Medium
i
6/11/2019CowenInitiated CoverageOutperform ➝ Outperform$21.00Medium
i
6/11/2019JPMorgan Chase & Co.Initiated CoverageOverweight ➝ Overweight$20.00Medium
i
6/11/2019UBS GroupInitiated CoverageBuy ➝ Buy$21.00Medium
i
6/11/2019The Goldman Sachs GroupInitiated CoverageBuy ➝ Buy$20.00 ➝ $20.00Medium
i
6/11/2019Piper Jaffray CompaniesInitiated CoverageNeutral ➝ Neutral$19.00Medium
i
(Data available from 11/28/2015 forward)
Avantor logo
Avantor, Inc. provides products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries worldwide. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, and clinical trial kits. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Read More

Today's Range

Now: $26.35
$26.16
$26.52

50 Day Range

MA: $25.21
$23.00
$27.60

52 Week Range

Now: $26.35
$6.66
$28.98

Volume

1,041,579 shs

Average Volume

4,424,284 shs

Market Capitalization

$15.24 billion

P/E Ratio

219.58

Dividend Yield

N/A

Beta

1.9